Pacira BioSciences (PCRX) Stock Price, Quote, News & History | Benzinga

Pacira BioSciences Inc (PCRX) Stock Price, Quote, News & History

PCRXNASDAQ

Trade with Public

Trade with Public

$25.24

0.873.57%

At close: Jun 26, 5:00 PM EST

$25.24

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Events Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$24.29

Close

$25.24

Volume / Avg.

1.02M / 522.75K

Day Range

$24.29 - $25.62

52 Wk Range

18.80 - 27.64

Market Cap

$992.51M

P/E Ratio

187.19

Dividend Yield

-

Exchange

NASDAQ

RSI

68

Short Interest

23.08%

Days to Cover

16.69

Recent Pacira Biosciences Inc News

Pacira Faces Board Fight As Activist Investor Criticizes CEO Pay, Missed Earnings

Activist investor DOMA nominates three directors to Pacira's board, citing weak oversight, missed earnings, and rising executive pay.

Vandana Singh

Pacira Settles Patent Dispute Over Exparel With Fresenius, Delays Pain Med' Generics Entry Until 2030, Stock Jumps

Pacira settles Exparel patent cases, grants Fresenius phased license for generic sales beginning in 2030, with full access no earlier than 2039.

Vandana Singh

Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate

Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

142.22M

Investing Cash Flow (TTM)

144.55M

Financing Cash Flow (TTM)

-426.03M

Free Cash Flow (TTM)

132.71M

Capital Expenditure (TTM)

-9.51M

Net Change in Cash (TTM)

-139.26M

Analyst Trends and Forecast

2

Jan

1

Mar

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.17B

PE Ratio (TTM)

187.19

PE Ratio (FWD)

8.31

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.45

PB Ratio (TTM)

1.46

Earnings Yield % (TTM)

0.53%

Earnings Yield % (FWD)

12.04%

EV / EBITDA (TTM)

9.85

Price / EBITDA (TTM)

8.97

Price / Free Cash Flow (TTM)

8.00

Book Value / Share

$16.62

Company Debt

Total Debt

$367.66M

LT Debt

$367.66M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$319.99M

Total Cash

$144.31M

Debt to Equity

0.63

Issuance of Debt (TTM)

-$218.99M

Repayment of Debt (TTM)

-$319.99M

Key Statistics

Open

$24.29

Close

$25.24

Volume / Avg.

1.02M / 522.75K

Day Range

$24.29 - $25.62

52 Wk Range

18.80 - 27.64

Market Cap

$992.51M

P/E Ratio

187.19

Dividend Yield

-

Exchange

NASDAQ

RSI

68

Short Interest

23.08%

Days to Cover

16.69

About

Sector

Health Care

Industry

Pharmaceuticals

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EX...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Pacira BioSciences (PCRX) stock?

A

You can purchase shares of Pacira BioSciences (NASDAQ:PCRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pacira BioSciences (PCRX) competitors?

A

There are no as such competitors for Pacira BioSciences.

Q

What is the forecast, or price target, for Pacira BioSciences (PCRX) stock?

A

Pacira BioSciences has a consensus price target of $34.53.

Q

What is the current price for Pacira BioSciences (PCRX)?

A

The stock price for Pacira BioSciences (NASDAQ: PCRX) is $25.24 last updated June 26, 2026 at 4:00 PM EDT.

Q

Does Pacira BioSciences (PCRX) pay a dividend?

A

There are no upcoming dividends for Pacira BioSciences.

Q

When is Pacira BioSciences (NASDAQ:PCRX) reporting earnings?

A

Pacira BioSciences does not have any upcoming earnings scheduled.

Q

Is Pacira BioSciences (PCRX) going to split?

A

There is no upcoming split for Pacira BioSciences.

Q

What sector and industry does Pacira BioSciences (PCRX) operate in?

A

Pacira BioSciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.